Toll Free: 1-888-928-9744
Published: Jun, 2014 | Pages:
46 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Stemline Therapeutics, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Stemline Therapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the Stemline Therapeutics, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Stemline Therapeutics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Stemline Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Stemline Therapeutics, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Stemline Therapeutics, Inc.'s pipeline products Reasons to buy - Evaluate Stemline Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Stemline Therapeutics, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Stemline Therapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Stemline Therapeutics, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Stemline Therapeutics, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Stemline Therapeutics, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Stemline Therapeutics, Inc. Snapshot 5 Stemline Therapeutics, Inc. Overview 5 Key Information 5 Key Facts 5 Stemline Therapeutics, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Stemline Therapeutics, Inc. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Stemline Therapeutics, Inc. - Pipeline Products Glance 11 Stemline Therapeutics, Inc. - Clinical Stage Pipeline Products 11 Phase II Products/Combination Treatment Modalities 11 Phase I Products/Combination Treatment Modalities 12 Stemline Therapeutics, Inc. - Early Stage Pipeline Products 13 Preclinical Products/Combination Treatment Modalities 13 Discovery Products/Combination Treatment Modalities 14 Stemline Therapeutics, Inc. - Drug Profiles 15 SL-401 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 SL-701 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Monoclonal Antibody Targeting CD133 For Cancer 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Monoclonal Antibody Targeting Frizzled Receptor For Cancer 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 Monoclonal Antibody Targeting Glypican-3 For Cancer 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Monoclonal Antibody Targeting Patched For Cancer 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Monoclonal Antibody Targeting Smoothened For Cancer 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 Monoclonal Antibody Targeting Tie-1 Receptor For Cancer 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 SL-101 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 SL-201 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 SL-202 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 SL-301 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 SL-302 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 SL-501 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 SL-601 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 Stemline Therapeutics, Inc. - Pipeline Analysis 32 Stemline Therapeutics, Inc. - Pipeline Products by Target 32 Stemline Therapeutics, Inc. - Pipeline Products by Route of Administration 34 Stemline Therapeutics, Inc. - Pipeline Products by Molecule Type 35 Stemline Therapeutics, Inc. - Pipeline Products by Mechanism of Action 36 Stemline Therapeutics, Inc. - Recent Pipeline Updates 38 Stemline Therapeutics, Inc. - Dormant Projects 43 Stemline Therapeutics, Inc. - Locations And Subsidiaries 44 Head Office 44 Appendix 45 Methodology 45 Coverage 45 Secondary Research 45 Primary Research 45 Expert Panel Validation 45 Contact Us 46 Disclaimer 46
List of Tables Stemline Therapeutics, Inc., Key Information 5 Stemline Therapeutics, Inc., Key Facts 5 Stemline Therapeutics, Inc. - Pipeline by Indication, 2014 7 Stemline Therapeutics, Inc. - Pipeline by Stage of Development, 2014 9 Stemline Therapeutics, Inc. - Monotherapy Products in Pipeline, 2014 10 Stemline Therapeutics, Inc. - Phase II, 2014 11 Stemline Therapeutics, Inc. - Phase I, 2014 12 Stemline Therapeutics, Inc. - Preclinical, 2014 13 Stemline Therapeutics, Inc. - Discovery, 2014 14 Stemline Therapeutics, Inc. - Pipeline by Target, 2014 33 Stemline Therapeutics, Inc. - Pipeline by Route of Administration, 2014 34 Stemline Therapeutics, Inc. - Pipeline by Molecule Type, 2014 35 Stemline Therapeutics, Inc. - Pipeline Products by Mechanism of Action, 2014 36 Stemline Therapeutics, Inc. - Recent Pipeline Updates, 2014 38 Stemline Therapeutics, Inc. - Dormant Developmental Projects,2014 43
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.